Core Insights - Nvidia and Eli Lilly have established a joint AI+Pharma lab, marking a shift in drug development from experience-driven to data and algorithm-driven approaches [2] - Tempus reported a revenue of approximately $1.27 billion for 2025, reflecting an 83% year-over-year growth, validating the commercialization potential of AI in clinical diagnostics and medical data [3] - The current phase is characterized by significant technological breakthroughs, active funding, and accelerated application of AI in the pharmaceutical industry [4] AI+Pharma - The AI+Pharma lab will leverage Eli Lilly's expertise in drug discovery and Nvidia's strengths in AI and computational infrastructure, with a planned investment of up to $1 billion over the next five years [2] - This collaboration signifies the integration of AI as a core productivity tool in drug development processes [2] AI+Healthcare - Tempus's diagnostic revenue reached approximately $955 million, up 111% year-over-year, driven by a 26% increase in tumor testing and a 29% increase in genetic testing [3] - The data and applications segment generated about $316 million, reflecting a 31% growth, with the Insights business growing by 38% [3] Industry Trends - The industry is experiencing a convergence of technological innovation, supportive policies, and a promising market outlook [4] - AI technologies have made significant advancements, enhancing efficiency across drug discovery, preclinical research, and clinical trials [4] - The AI pharmaceutical investment landscape is active, with notable developments such as OpenAI's ChatGPT Health and a surge in user engagement [4] Related Companies - AI Drug Discovery: Crystal Technology (02228), Insilico Medicine (03696), Via Biotechnology (01873), Chengdu XianDao (688222.SH), Hongbo Pharmaceutical (301230.SZ), and Yaoshi Technology (300725.SZ) [5] - AI Applications/Healthcare: Meinian Health (002044.SZ), Kingmed Diagnostics (603882.SH), Yuyue Medical (002223.SZ), BGI Genomics (688114.SH), and Dian Diagnostics (300244.SZ) [5]

Core Viewpoint - Haitong International maintains an "outperform" rating for Li Ning (02331) and raises the target price by 6% to HKD 22.3, indicating a potential upside of 13.9% [1] Financial Projections - Revenue projections for Li Ning from 2025 to 2027 are expected to reach RMB 28.79 billion, RMB 30.1 billion, and RMB 31.69 billion, representing year-on-year growth of 0.4%, 4.5%, and 5.3% respectively [1] - Net profit attributable to shareholders for the same period is forecasted to be RMB 2.64 billion, RMB 2.72 billion, and RMB 3.01 billion, corresponding to price-to-earnings ratios of 17.2x, 16.7x, and 15.1x respectively [1] Strategic Outlook - The adjustment of product categories and channels for Li Ning is expected to conclude this year, with the company planning to increase resource allocation and marketing efforts [1] - Haitong International is optimistic about the long-term brand strength and consumer perception that will result from these investments [1]

Group 1 - The core viewpoint of the report is that Haitong International maintains an "outperform" rating for Li Ning (02331) and raises the target price by 6% to HKD 22.3, indicating a potential upside of 13.9% [1] - Li Ning's category and channel adjustments are expected to be completed this year, with the company planning to increase resource allocation and promotional efforts [1] - Haitong International forecasts Li Ning's revenue for 2025, 2026, and 2027 to be RMB 28.79 billion, RMB 30.1 billion, and RMB 31.69 billion respectively, with year-on-year growth rates of 0.4%, 4.5%, and 5.3% [1] Group 2 - The expected net profit attributable to the parent company for the same years is RMB 2.64 billion, RMB 2.72 billion, and RMB 3.01 billion, corresponding to price-to-earnings ratios of 17.2x, 16.7x, and 15.1x respectively [1] - The report emphasizes the positive impact of Li Ning's investments on long-term brand strength and consumer perception [1]

Group 1 - The three major indices collectively declined, with the CSI Chip Industry Index (H30007.CSI) falling by 1.13%. Notable stocks within this index included Unigroup Guowei hitting the daily limit, Baiwei Storage rising nearly 5%, Jiangbolong increasing over 2%, and Shengmei Shanghai and Yake Technology both up nearly 2% [1] - The chip ETF Tianhong (159310) experienced a midday drop, with a transaction volume of 6.3427 million yuan and a real-time premium rate of 0.23% [1] - Unigroup Guowei announced a restructuring plan to acquire 100% of Ruineng Semiconductor Technology Co., Ltd. through a combination of share issuance and cash payment, aiming to enhance its power semiconductor product matrix and complete its semiconductor industry chain layout [1] Group 2 - Haitong International's research report indicated that after a continuous market rise, a certain degree of fluctuation is expected this week, presenting a good opportunity to continue positioning for the spring market [2] - The A-share market outperformed the US stock market last week, with the sentiment for the spring market shifting back to the main line of commercial aerospace, expanding further into AI applications, nuclear fusion, and robotics [2] - The market is anticipated to further consolidate the "technology financing" narrative as IPOs from companies like Changxin, Yushu, Kunlunxin, and Chaogufen continue to progress [2]

Core Viewpoint - The express delivery industry is expected to maintain a single-digit growth rate, with a projected year-on-year increase of 5% in November 2025, reflecting a slowdown in growth compared to previous years [1][2]. Group 1: Industry Growth and Performance - The express delivery volume during the e-commerce Double Eleven shopping festival is expected to increase by 9% year-on-year, a significant decrease from the 21% growth rate observed in 2024 [1][2]. - The average daily volume during the shopping festival is 1.18 times that of regular days, with a peak daily volume increase of 6.6% year-on-year, indicating a diminishing marginal effect of the shopping festival on consumer spending [2][3]. Group 2: Revenue and Market Share - The implementation of anti-involution policies has effectively increased the revenue per package, with YTO, Yunda, and Shentong seeing revenue increases of 0.16, 0.25, and 0.44 yuan respectively from July to November [3]. - The market concentration in the express delivery sector has stabilized, with the CR8 index remaining at 86.9 in November, indicating a balanced market share among major players [3]. - The market shares for Zhongtong, YTO, Yunda, Shentong, and Jitu in Q3 2025 were 19.4%, 15.6%, 13.0%, 13.2%, and 11.3% respectively, showing slight fluctuations [3]. Group 3: Profitability Recovery - The anti-involution measures have contributed to a recovery in profitability, with Zhongtong, YTO, Yunda, and Shentong reporting net profit margin changes of -0.9%, +0.07%, -1.5%, and +0.5% year-on-year respectively [3]. - The trend of profitability recovery is expected to continue into Q4, contingent on the sustained implementation of anti-involution policies [3][4]. Group 4: Regulatory Environment and Competitive Strategies - The anti-involution policies initiated by the State Post Bureau have effectively countered "involution-style" competition, supported by local postal authorities through price and market share supervision [4]. - The positive effects of the anti-involution measures are anticipated to continue, promoting healthy competition and profitability within the industry [4]. Group 5: Investment Recommendations - The express delivery sector is viewed positively, with recommendations for leading companies such as Zhongtong Express and Jitu Express, which are expected to benefit from improved profitability and high growth in overseas volumes [5]. - SF Express is noted for its proactive market expansion strategy, which is expected to yield positive results as cost control measures are strengthened [5].

Core Viewpoint - Haitong International forecasts that Hu Shang A Yi (02589) will achieve revenues of 4.22 billion, 4.92 billion, and 5.63 billion CNY in 2025, 2026, and 2027 respectively, with adjusted net profits of 540 million, 620 million, and 710 million CNY for the same years, assigning a target price of 105 HKD based on a 16X PE valuation for 2026, and initiating coverage with an outperform rating [1] Group 1: Company Overview - Hu Shang A Yi is a leading fresh beverage company in China, expected to surpass 10,000 stores by the end of 2025, becoming the third fresh tea beverage brand in the country to achieve this milestone [2] - The company is leveraging a "one body, two wings" business model, focusing on the Hu Shang A Yi brand in China while also developing the Cha Pu Bu brand and expanding internationally [2][3] Group 2: Business Strategy - The company has successfully expanded its store network in northern markets by adopting a franchise model, sharing resources, and incentivizing external talent, which has contributed to its rapid growth [2] - The brand's marketing strategy emphasizes health and wellness, targeting female consumers through branding and product offerings, which has helped in customer acquisition [2] - The low-threshold store model and inclusive franchise system have allowed for sustainable expansion, with new franchisees expected to reinvest profits into opening additional stores [2] Group 3: Financial Forecast - The company is projected to open over 2,000 new Hu Shang A Yi stores and more than 1,000 new Cha Pu Bu stores by 2026, indicating a stable growth trajectory [4] - The company anticipates that same-store sales will remain stable in 2026, despite a high base from delivery subsidies in 2025, by enhancing coffee offerings and increasing marketing efforts [4]

Core Viewpoint - Haitong International expects Hu Shang Ayi (02589) to achieve revenues of 4.22 billion, 4.92 billion, and 5.63 billion CNY for the years 2025-2027, with adjusted net profits of 540 million, 620 million, and 710 million CNY respectively, assigning a target price of 105 HKD based on a 16X PE valuation for 2026, and initiating coverage with an outperform rating [1] Group 1: Company Overview - Hu Shang Ayi is a leading fresh beverage company in China, projected to surpass 10,000 stores by the end of 2025, becoming the third fresh tea beverage brand in the country to achieve this milestone [2] - The company is leveraging its scale and channel advantages to strengthen its position in the market, as the window for new brands to rapidly scale has closed, leading to a landscape where strong brands will dominate [2] Group 2: Business Strategy - The company operates with a "one body, two wings" business model, focusing on Hu Shang Ayi in China and the Tea Waterfall brand along with overseas markets as growth drivers [3] - Hu Shang Ayi's rapid expansion is attributed to its effective management philosophy, which emphasizes mutual benefits and resource sharing, as well as a focus on health-oriented products targeting specific customer demographics [3] - The company has established a low-threshold store model and an inclusive franchise system, which allows for sustainable expansion through new franchisee investments and improved single-store profitability [3] Group 3: Growth Engines - The Tea Waterfall brand is designed for lower-tier markets, creating a distinct identity while benefiting from the main brand's resources, while overseas expansion targets developed markets with successful store openings [4] - Both channel penetration and international expansion are seen as correct strategic directions for the brand, with significant potential for growth as these initiatives are still in their early stages [4] Group 4: Financial Forecast - The company is expected to stabilize its market share with over 2,000 new Hu Shang Ayi stores and over 1,000 new Tea Waterfall stores by 2026, with same-store sales expected to remain stable despite high bases due to delivery subsidies in 2025 [5]

Group 1 - The core viewpoint of Haitong International is to maintain an "outperform" rating for Maogeping (01318), with a target price of HKD 108.2, indicating a potential upside of 23.1% based on a 32X PE for 2026. The firm believes that the brand strength and fundamentals remain solid, with the company's core value lying in its strong high-end brand positioning and continuous product innovation [1] Group 2 - Haitong International expects Maogeping to continue strong growth in the second half of 2025, benefiting from robust offline same-store performance driven by sales volume, despite a weakening consumer spending power in the latter half of the year. The expansion of membership and high repurchase rates support sales growth [2] - The company is projected to achieve revenues of RMB 5.101 billion, RMB 6.489 billion, and RMB 8.115 billion for 2025-2027, representing year-on-year growth of 31.3%, 27.2%, and 25.0% respectively. Net profit attributable to the parent company is expected to be RMB 1.201 billion, RMB 1.494 billion, and RMB 1.848 billion for the same period, with growth rates of 36.4%, 24.4%, and 23.7% respectively [2] Group 3 - The company has signed a strategic agreement with investment institution Luwei Kaiteng to inject internationalization and capitalization momentum, focusing on global market expansion, establishing a high-end beauty investment fund, and optimizing corporate governance. This collaboration is expected to significantly enhance the company's penetration in overseas high-end markets and open up avenues for future growth through the investment fund platform [3] Group 4 - The company's controlling shareholders and some directors plan to reduce their holdings by up to 3.51% of the total share capital, equating to a maximum of 1,720 shares, valued at approximately HKD 15.1 billion based on the closing price of HKD 87.95 per share on January 7. The reduction is primarily for personal financial planning, and the company emphasizes that this will not lead to a change in control, as the founding family will maintain around 70% ownership [4]

Group 1 - The core viewpoint of Haitong International is to maintain an "outperform" rating for Maogeping (01318), with a target price of HKD 108.2, indicating a potential upside of 23.1% based on a 32X PE for 2026. The firm believes in the company's strong brand power and fundamentals, highlighting its high-end brand positioning and continuous product innovation as key value drivers [1][2]. Group 2 - It is anticipated that Maogeping will continue its strong growth in the second half of 2025, benefiting from robust offline same-store performance driven by sales volume, despite a weakening consumer spending environment. The expansion of membership and high repurchase rates are expected to support sales growth [2]. - The company is projected to achieve revenues of CNY 5.101 billion, CNY 6.489 billion, and CNY 8.115 billion for 2025-2027, reflecting year-on-year growth rates of 31.3%, 27.2%, and 25.0%, respectively. Net profit attributable to the parent company is expected to be CNY 1.201 billion, CNY 1.494 billion, and CNY 1.848 billion, with growth rates of 36.4%, 24.4%, and 23.7% [2]. Group 3 - The company has signed a strategic agreement with investment institution Luwei Kaiteng to inject internationalization and capitalization momentum, focusing on global market expansion, establishing a high-end beauty investment fund, and optimizing corporate governance. Successful implementation of this cooperation is expected to significantly enhance the company's penetration in overseas high-end markets [3]. Group 4 - The company's controlling shareholders and some directors plan to reduce their holdings by up to 3.51% of the total share capital, equating to a maximum of 1,720 shares, valued at approximately HKD 15.1 billion based on the closing price of HKD 87.95 per share on January 7. The company emphasizes that this reduction will not lead to a change in control, as Maogeping and its relatives will maintain around 70% of the company's equity [4].

Company Overview - Laoxiangji has submitted an application for listing on the Hong Kong Stock Exchange, with CICC and Haitong International as joint sponsors [1] - As of August 31, 2025, Laoxiangji operates 1,658 stores across 61 cities in China, comprising 925 direct-operated stores and 733 franchised stores, establishing a "direct + franchise" store network [1] - The company is recognized as one of the first Chinese fast-food companies to implement standardization across the entire value chain and to adopt digital intelligence [1] - Laoxiangji is the only major Chinese fast-food company with a fully integrated supply chain and a comprehensive traceability system [1] Industry Insights - In 2024, Laoxiangji holds a 0.9% market share, ranking first in the Chinese fast-food industry and eighth in the overall fast-food sector [1] - The Chinese fast-food market is dominated by Chinese-style fast food, with a market size of 809.7 billion RMB in 2024, projected to grow to 1,205.8 billion RMB by 2029, reflecting a compound annual growth rate (CAGR) of 8.3% from 2024 to 2029 [1] - Among the top five Chinese fast-food companies, Laoxiangji ranks first in terms of average daily sales per store (15,100 RMB) and average table turnover rate (4.4) in 2024 [1]